Zoetis India Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U46497MH2007PLC203686 Incorporated 06 September 2007 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹402.08 Cr
▲ 30% YoY
Net profit · FY 2025
₹28.72 Cr
Net margin 7.1%
EBITDA · FY 2025
₹60.68 Cr
EBITDA margin 15.1%
Authorised capital
₹568.75 Cr
Registered with MCA
Paid-up capital
₹13.5 Cr
Issued & subscribed
Satisfied charges
₹64.37 Cr
No open charges
Company age
19 yrs
Est. 2007
Employees · EPFO
127
Provident fund records

About Zoetis India Limited

Data last updated:

Zoetis India Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Zoetis Pharmaceutical Research Private Limited. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 06 September 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U46497MH2007PLC203686. Its GSTIN is 27AABCE8269K1Z5 (Maharashtra). The company holds 10 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹568.75 Cr and a paid-up capital of ₹13.5 Cr. It was formerly known as Vetnex Animal Health Private Limited and Vetnex Animal Health Limited. It is led by directors including Ashwini Shrikant Deshpande (Managing Director) and Jaydip Chatterjee (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 31 3rd Floor Kalpataru Synergy Opp. : Grand Hyatt Santacruz(E), Mumbai, Maharashtra, India – 400055.

As per the financials filed for FY 2025, the company reported a revenue of ₹402.08 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹28.72 Cr (net margin 7.1%) and EBITDA of ₹60.68 Cr (EBITDA margin 15.1%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 15% over five years.

The company has about 127 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Zoetis. As per MCA filings, the company has satisfied charges of ₹64.37 Cr on record. Court records list 90 cases involving the company, including 81 filed by the company and 9 filed against it; 6 cases are pending. The company has 5 deals on record (2 secondary share transfers, 2 acquisitions, 1 funding round), with disclosed funding of ₹6.58 Cr; the latest was in December 2012. The company has 9 MSME Form 1 returns on record between 2020 and 2024, listing 35 overdue payments to 14 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zoetis.in.

Company details

CIN U46497MH2007PLC203686
Registration Number 203686
Incorporation Date 06 September 2007
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Zoetis Pharmaceutical Research Private Limited
Compliance Status Active Compliant

Name history

Zoetis India has undergone 5 name changes throughout its history. The current legal name is Zoetis India Limited.

Company NameStatus
Zoetis India LimitedCurrent
Vetnex Animal Health Private LimitedPrevious
Vetnex Animal Health LimitedPrevious
Elegant E-Services Private LimitedPrevious
Pfizer Animal Health India LimitedPrevious
Vetnex Animal Health LimitedPrevious

CIN history

Zoetis India has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U46497MH2007PLC203686, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U46497MH2007PLC203686Current
U93000MH2007PLC203686Previous
U93000DL2007PLC167809Previous
U93000DL2007PTC167809Previous

Contact details

Zoetis India Limited's registered office is in Mumbai, Maharashtra. Its website is zoetis.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Social Media
  • Registered Address
    31 3rd Floor Kalpataru Synergy Opp. : Grand Hyatt Santacruz(E), Mumbai, Maharashtra, India – 400055
  • Industry
    Pharma, Animal Pharmaceuticals & Healthcare

To see the full contact details of Zoetis India Limited, buy the company report.

Comprehensive company report
Zoetis India Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Zoetis India operates one associated brand: Zoetis. Each brand links to its own profile.

BrandDescriptionWebsite
Animal medicines, vaccines, and diagnostics are manufactured and supplied.zoetis.com

Business activity

The main business activity of Zoetis India is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Zoetis India Limited, buy the company report.

Financials of Zoetis India Limited

FY 2024 filings available

Zoetis India Limited reported revenue of ₹402.08 Cr (up 30% YoY) for FY 2025.

Revenue · FY 2025
₹402.08 Cr ▲ 30%
Net profit · FY 2025
₹28.72 Cr margin 7.1%
EBITDA · FY 2025
₹60.68 Cr margin 15.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 18%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 52%
3 years · compounded
▲ 8%
5 years · compounded
▲ 14%

Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 30% growth in the latest year. EBITDA rose 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹60.68 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹28.72 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin15.1%
Net Profit Margin7.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Zoetis India Limited, buy the company report.

Board of directors of Zoetis India Limited

Zoetis India has 3 current directors and 24 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Jaydip ChatterjeeWhole-Time Director12 Sep 20224 Years 1 MonthsCurrent
Ashwini Shrikant DeshpandeManaging Director30 Sep 20233 Years 0 MonthsCurrent
Resha Mahabaleshwar KantakWhole-Time Director06 Apr 201214 Years 6 MonthsCurrent

Auditor

Zoetis India Limited is audited by MSKA & Associates for the financial year 2022.

Auditor firmFinancial yearFirm registration number
MSKA & AssociatesFY 2022105047W

Shareholding

The shareholding of Zoetis India Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Zoetis India Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹64.37 Cr
Breakdown by lending institutions
State Bank of India (Mid Corporate Loan Administrative Unit)₹33.33 Cr
Yes Bank Limited₹17.51 Cr
Icici Bank Limited₹7.00 Cr
Indian Overseas Bank₹6.53 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Aug 200910176455Icici Bank Limited₹7 CrSatisfied
17 Aug 200910173980State Bank of India (Mid Corporate Loan Administrative Unit)₹33.33 CrSatisfied
06 Aug 200910177266Yes Bank Limited₹17.51 CrSatisfied
26 Sep 200380016376Indian Overseas Bank₹1.9 CrSatisfied
26 Sep 200380016375Indian Overseas Bank₹4.63 CrSatisfied

To see the full charge records of Zoetis India Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Zoetis India Limited has 5 deals on record (2 secondary share transfers, 2 acquisitions, 1 funding round), with disclosed funding of ₹6.58 Cr; the latest was in December 2012.

Total deals
5
Secondary share transfers
2
Acquisitions
2
Funding round
1
Disclosed funding
₹6.58 Cr

Deals on record (3 of 5)

WhenDealAmountParties
Dec 2012Acquisition₹473.3 CrBuyer: Zoetis Pharmaceutical Research Private Limited
Jun 2009Funding round₹6.58 CrInvestors: Icici Venture, Man GLG (GLG Partners), 2 individuals
Oct 2008AcquisitionUndisclosedBuyer: Avantor Performance Materials India Private Limited
Seller: 2 individuals

To see the full deal history of Zoetis India Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Zoetis India Limited has 9 MSME Form 1 returns on record between 2020 and 2024, listing 35 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 14)

SupplierAmount dueDue sinceReported on
J J Parikh Pharma Pvt Ltd
an individual supplier
Ishta Siddhi Vinayaka Pharma Private Limited
SD Cargo Private Limited
K R Logistics

To see the full MSME payment records of Zoetis India Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Zoetis India Limited has a workforce of 127 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.

Employee count
127
Active EPFO establishments
1
Employee growth
8.55%

GST

Zoetis India has 10 GST registrations: 1 active and 9 cancelled or inactive.

Total GSTINs
10
Active
1
Cancelled / inactive
9
GSTINStateStatusRegistered on
27AABCE8269K1Z5MaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Zoetis India Limited, buy the company report.

Recent activity

Zoetis India Limited has 27 board changes on record since 2008: 3 appointments and 24 cessations. The latest: Ashwini Shrikant Deshpande was appointed as Managing Director on 30 Sep 2023.

AGM
Zoetis India Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Zoetis India Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Appointed
Ashwini Shrikant Deshpande was appointed as Managing Director.
Ceased
Ashwini Shrikant Deshpande ceased to be Additional Director.
Ceased
Jaydip Chatterjee ceased to be Additional Director.
Ceased
Sandip Sharad Joshi ceased to be Director.
Ceased
Smita Manish Mahajan ceased to be Director.
Appointed
Jaydip Chatterjee was appointed as Whole-Time Director.
Ceased
Hari Prasad Yethirajyam ceased to be Managing Director.
Ceased
Ketan Ramesh Dhamanaskar ceased to be Managing Director.
Ceased
Siddharth Suresh Shah ceased to be Director.
Ceased
Deepak Mohanlal Jain ceased to be Director.

29 earlier events are in the company report.

Frequently asked questions

Zoetis India is an active public limited company based in Mumbai, Maharashtra, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 06 September 2007 (19+ years old) and is registered under CIN U46497MH2007PLC203686.

Zoetis India has 3 current directors:

The latest financial statements of Zoetis India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Zoetis India is 27AABCE8269K1Z5, registered in Maharashtra. The company has 10 GST registrations in all, of which 1 is active and 9 are cancelled or inactive.

The CIN (Corporate Identification Number) of Zoetis India is U46497MH2007PLC203686. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Zoetis India has 90 court cases on record: 81 filed by the company and 9 filed against it. 6 are pending. Most are in the district courts.

Zoetis India was incorporated on 06 September 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.

Zoetis India has 5 deals on record (2 secondary share transfers, 2 acquisitions, 1 funding round), with disclosed funding of ₹6.58 Cr; the latest was in December 2012.

Ashwini Shrikant Deshpande was appointed as Managing Director on 30 Sep 2023. Ashwini Shrikant Deshpande ceased to be Additional Director on 10 Mar 2023. Jaydip Chatterjee ceased to be Additional Director on 30 Sep 2022. Zoetis India has 27 board changes on record in total.

Zoetis India has 9 MSME Form 1 returns on record between 2020 and 2024, listing 35 overdue payments to 14 micro and small suppliers. The latest return was filed on 26 Apr 2024.

Zoetis India can be reached through the website zoetis.in. Its registered office is in Mumbai, Maharashtra, India.